Schimke immunoosseous dysplasia and management considerations for vascular risks.
Anticholesteremic Agents
/ therapeutic use
Antihypertensive Agents
/ therapeutic use
Arteriosclerosis
/ complications
Atorvastatin
/ therapeutic use
Benzazepines
/ therapeutic use
Blood Pressure
Blood Pressure Monitoring, Ambulatory
Child
DNA Helicases
/ genetics
Disease Management
Dyslipidemias
/ complications
Female
Gene Expression
Headache
/ complications
Humans
Hypertension
/ complications
Mutation
Nephrotic Syndrome
/ complications
Osteochondrodysplasias
/ complications
Primary Immunodeficiency Diseases
/ complications
Propranolol
/ therapeutic use
Pulmonary Embolism
/ complications
SMARCAL1
Schimke
atherosclerosis
immunoosseus
lentigines
skeletal dysplasia
stroke
Journal
American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
28
09
2018
revised:
31
01
2019
accepted:
22
02
2019
pubmed:
1
5
2019
medline:
9
6
2020
entrez:
1
5
2019
Statut:
ppublish
Résumé
Schimke immunoosseous dysplasia (SIOD) is a multisystemic condition characterized by early arteriosclerosis and progressive renal insufficiency, among other features. Many SIOD patients have severe, migraine-like headaches, transient neurologic attacks, or cerebral ischemic events. Cerebral events could be exacerbated or precipitated by hypertension, and it is unclear how these are related to arteriosclerotic changes as dyslipidemia is also a feature of SIOD. The correlation between hypercholesterolemia and cardiovascular risk in SIOD is unclear. Also, the etiology and management of headaches is not well characterized. Here we report our clinical observations in the management of SIOD in a patient who was diagnosed in school age despite early signs and symptoms. We describe biallelic variants, including a previously unreported c.1931G>A (p.Arg644Gln) variant in SMARCAL1. We specifically investigated whether migraine-like headaches and progressive nephropathy may be related to blood pressure dysregulation. We found a correlation between tighter blood pressure regulation using ambulatory blood pressure monitoring and a subjective decrease in headache symptoms. We discuss blood pressure medication management in SIOD. We also characterize dyslipidemia relative to atherosclerosis risks and provide new management strategies to consider for optimizing care.
Identifiants
pubmed: 31039288
doi: 10.1002/ajmg.a.61148
doi:
Substances chimiques
Anticholesteremic Agents
0
Antihypertensive Agents
0
Benzazepines
0
Propranolol
9Y8NXQ24VQ
Atorvastatin
A0JWA85V8F
SMARCAL1 protein, human
EC 2.7.7.-
DNA Helicases
EC 3.6.4.-
benazepril
UDM7Q7QWP8
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1246-1252Informations de copyright
© 2019 Wiley Periodicals, Inc.